Table 2

Patient backgrounds with and without IFN treatment
IFN treated Group A (n = 154) SVR Group A1 (n = 72) Non-SVR Group A2 (n = 82) No treated Group B (n = 328)
Male 117 (76.0%) 56 (77.8%) 62 (75.6%) 205 (62.5%)
Age at first visit (mean ± SD), years 56.9 ± 11.5 55.7 ± 12.6 58.0 ± 10.3 57.5 ± 10.4
ALT < 40 IU/mL 2 (1.3%) 0 (0%) 2 (2.4%) 129 (39.4%)

Yamasaki et al.

Yamasaki et al. BMC Gastroenterology 2012 12:139   doi:10.1186/1471-230X-12-139

Open Data